Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antibody Structure01:10

Antibody Structure

65.4K
Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.4K
Antibody Structure and Classes01:25

Antibody Structure and Classes

8.4K
Antibodies, also known as immunoglobulins, are produced by B cells in response to foreign substances, such as bacteria and viruses. These proteins are critical for recognizing and neutralizing these substances, protecting the body from potential harm.
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.
8.4K
Drug Discovery: Overview01:26

Drug Discovery: Overview

11.2K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.2K
Light Acquisition02:16

Light Acquisition

9.4K
In order to produce glucose, plants need to capture sufficient light energy. Many modern plants have evolved leaves specialized for light acquisition. Leaves can be only millimeters in width or tens of meters wide, depending on the environment. Due to competition for sunlight, evolution has driven the evolution of increasingly larger leaves and taller plants, to avoid shading by their neighbors with contaminant elaboration of root architecture and mechanisms to transport water and nutrients.
9.4K
Additional Subnuclear Structures02:10

Additional Subnuclear Structures

5.3K
The eukaryotic nucleus is a double membrane-bound organelle that contains nearly all of the cell’s genetic material in the form of chromosomes. It is rightly called the “brain” of the cell as it shoulders the responsibility of responding to various physiological processes, stress, altered metabolic conditions, and other cellular signals. 
The nucleus contains many membrane-less subnuclear organelles or nuclear bodies, such as nucleoli, Cajal bodies, speckles,...
5.3K
Photoreceptors and Plant Responses to Light02:00

Photoreceptors and Plant Responses to Light

28.3K
Light plays a significant role in regulating the growth and development of plants. In addition to providing energy for photosynthesis, light provides other important cues to regulate a range of developmental and physiological responses in plants.
28.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Geometric parameters that affect the behavior of logic-gated CAR T cells.

Frontiers in immunology·2024
Same author

AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer.

Cancer discovery·2023
Same author

HLA-A∗02-gated safety switch for cancer therapy has exquisite specificity for its allelic target antigen.

Molecular therapy oncolytics·2022
Same author

A Non-radiometric Approach to Determine Tissue Vascular Blood Volume in Biodistribution Studies.

The AAPS journal·2022
Same author

Development of an immunoassay for aglycosylated murine IgG1 in mouse serum via generation of a specific tool antibody.

Bioanalysis·2022
Same author

Metal-Free Polymer-Based Affinity Medium for Selective Purification of His6-Tagged Proteins.

Biomacromolecules·2021

Related Experiment Video

Updated: Jan 23, 2026

Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery
08:38

Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery

Published on: October 4, 2018

21.8K

Rapid single B cell antibody discovery using nanopens and structured light.

Aaron Winters1, Karyn McFadden1, John Bergen2

  • 1a Department of Therapeutic Discovery, Amgen Research , Thousand Oaks , CA , USA.

Mabs
|June 13, 2019
PubMed
Summary

We developed NanOBlast, a rapid single B cell screening method for generating therapeutic antibody reagents. This technique accelerates the discovery of high-affinity anti-idiotypic monoclonal antibodies for drug development.

Keywords:
ASCELISAMonoclonal antibodyNanOBlastOEPOptoElectro Positioningantibody discoveryantibody generationnanofluidicsstructured light

More Related Videos

Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells
06:53

Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells

Published on: June 2, 2022

3.7K
Single Particle Cryo-Electron Microscopy: From Sample to Structure
11:52

Single Particle Cryo-Electron Microscopy: From Sample to Structure

Published on: May 29, 2021

9.6K

Related Experiment Videos

Last Updated: Jan 23, 2026

Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery
08:38

Phospho Flow Cytometry with Fluorescent Cell Barcoding for Single Cell Signaling Analysis and Biomarker Discovery

Published on: October 4, 2018

21.8K
Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells
06:53

Rapid Antibody Glycoengineering in Chinese Hamster Ovary Cells

Published on: June 2, 2022

3.7K
Single Particle Cryo-Electron Microscopy: From Sample to Structure
11:52

Single Particle Cryo-Electron Microscopy: From Sample to Structure

Published on: May 29, 2021

9.6K

Area of Science:

  • Biotechnology
  • Immunology
  • Drug Development

Background:

  • Accelerated development of monoclonal antibody (mAb) tool reagents is crucial for therapeutic antibody advancement.
  • The drug development market demands faster and more efficient methods for generating essential reagents.

Purpose of the Study:

  • To describe a novel nanofluidic optoelectronic single B lymphocyte antibody screening technique (NanOBlast).
  • To apply NanOBlast for the rapid generation of anti-idiotypic reagent antibodies.
  • To develop a sensitive assay for quantifying therapeutic IgG molecules in patient serum.

Main Methods:

  • Utilized NanOBlast, a high-content culture and assay platform, to screen single antibody secreting cells (ASCs).
  • Employed microfluidic chip nanopens and structured light for cell manipulation and screening.
  • Integrated single-cell PCR, recombinant IgG expression, and ELISA for antibody characterization.

Main Results:

  • Successfully recovered and identified a diverse panel of high-affinity anti-idiotypic reagent mAbs.
  • Developed a sensitive and specific ligand binding assay for quantifying free therapeutic IgG in human serum.
  • Achieved a 5-hour workflow for cell screening on-chip and under 60 days for the overall discovery process.

Conclusions:

  • NanOBlast offers a direct, flexible, and rapid method for generating critical mAb tool reagents.
  • The developed assay facilitates crucial drug development decision-making by enabling precise therapeutic IgG quantification.
  • This technology significantly accelerates the timeline for therapeutic antibody reagent discovery and development.